References
- Abbott, R., Ross, G., White, L., Tanner, C., Masaki, K., Nelson, J., Curb, J., and Petrovitch, H. (2005). Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65, 1442-1446. https://doi.org/10.1212/01.wnl.0000183056.89590.0d
- Akiyama, H., and McGeer, P.L. (1989). Microglial response to 6-hydroxydopamine-induced substantia nigra lesions. Brain Res. 489, 247-253. https://doi.org/10.1016/0006-8993(89)90857-3
-
Alvarez-Fischer, D., Henze, C., Strenzke, C., Westrich, J., Ferger, B., Hoglinger, G.U., Oertel, W.H., and Hartmann, A. (2008). Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and
${\alpha}$ -synuclein-deleted mice. Exp. Neurol. 210, 182-193. https://doi.org/10.1016/j.expneurol.2007.10.012 - Banerjee, S., Wang, Y., Solt, L.A., Griffett, K., Kazantzis, M., Amador, A., El-Gendy, B.M., Huitron-Resendiz, S., Roberts, A.J., Shin, Y., et al. (2014). Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour. Nat. Commun. 5, 5759. https://doi.org/10.1038/ncomms6759
- Bechtold, D.A., Gibbs, J.E., and Loudon, A.S. (2010). Circadian dysfunction in disease. Trends. Pharmacol. Sci. 31, 191-198. https://doi.org/10.1016/j.tips.2010.01.002
-
Blum-Degena, D., Muller, T., Kuhn, W., Gerlach, M., Przuntek, H., and Riederer, P. (1995). Interleukin-1
${\beta}$ and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci. Lett. 202, 17-20. https://doi.org/10.1016/0304-3940(95)12192-7 - Breen, D.P., Vuono, R., Nawarathna, U., Fisher, K., Shneerson, J.M., Reddy, A.B., and Barker, R.A. (2014). Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 71, 589-595. https://doi.org/10.1001/jamaneurol.2014.65
- Chung, S., Lee, E.J., Yun, S., Choe, H.K., Park, S.B., Son, H.J., Kim, K.S., Dluzen, D.E., Lee, I., Hwang, O., et al. (2014). Impact of circadian nuclear receptor REV-ERBalpha on midbrain dopamine production and mood regulation. Cell 157, 858-868. https://doi.org/10.1016/j.cell.2014.03.039
- Comella, C.L. (2006). Sleep disturbances and excessive daytime sleepiness in Parkinson disease: an overview. J. Neural Transm. Suppl. 70, 349-355.
- Dauer, W., and Przedborski, S. (2003). Parkinson's disease: mechanisms and models. Neuron 39, 889-909. https://doi.org/10.1016/S0896-6273(03)00568-3
-
Everett, L.J., and Lazar, M.A. (2014). Nuclear receptor Rev-erb
${\alpha}$ : up, down, and all around. Trends. Endocrinol. Metab. 25, 586-592. https://doi.org/10.1016/j.tem.2014.06.011 -
Ferrari, C.C., Godoy, M.C.P., Tarelli, R., Chertoff, M., Depino, A.M., and Pitossi, F.J. (2006). Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1
${\beta}$ in the substantia nigra. Neurobiol. Dis. 24, 183-193. https://doi.org/10.1016/j.nbd.2006.06.013 - Fifel, K., Vezoli, J., Dzahini, K., Claustrat, B., Leviel, V., Kennedy, H., Procyk, E., Dkhissi-Benyahya, O., Gronfier, C., and Cooper, H.M. (2014). Alteration of daily and circadian rhythms following dopamine depletion in MPTP treated non-human primates. PLoS One 9, e86240. https://doi.org/10.1371/journal.pone.0086240
- Fonken, L.K., Frank, M.G., Kitt, M.M., Barrientos, R.M., Watkins, L.R., and Maier, S.F. (2015). Microglia inflammatory responses are controlled by an intrinsic circadian clock. Brain Behav. Immun. 45, 171-179. https://doi.org/10.1016/j.bbi.2014.11.009
-
Gibbs, J.E., Blaikley, J., Beesley, S., Matthews, L., Simpson, K.D., Boyce, S.H., Farrow, S.N., Else, K.J., Singh, D., Ray, D.W., et al. (2012). The nuclear receptor REV-ERB
${\alpha}$ mediates circadian regulation of innate immunity through selective regulation of inflammatory cytokines. Proc. Natl. Acad. Sci. USA 109, 582-587. https://doi.org/10.1073/pnas.1106750109 - Gu, Z., Wang, B., Zhang, Y.B., Ding, H., Zhang, Y., Yu, J., Gu, M., Chan, P., and Cai, Y. (2015). Association of ARNTL and PER1 genes with Parkinson's disease: a case-control study of Han Chinese. Sci. Rep. 5, 15891. https://doi.org/10.1038/srep15891
- Guillaumond, F., Dardente, H., Giguere, V., and Cermakian, N. (2005). Differential control of Bmal1 circadian transcription by REVERB and ROR nuclear receptors. J. Biol. Rhythms 20, 391-403. https://doi.org/10.1177/0748730405277232
- Haas, S.J., Zhou, X., Machado, V., Wree, A., Krieglstein, K., and Spittau, B. (2016). Expression of Tgfbeta1 and Inflammatory Markers in the 6-hydroxydopamine Mouse Model of Parkinson's Disease. Front. Mol. Neurosci. 9, 7.
- Hayashi, A., Matsunaga, N., Okazaki, H., Kakimoto, K., Kimura, Y., Azuma, H., Ikeda, E., Shiba, T., Yamato, M., Yamada, K.i., et al. (2013). A disruption mechanism of the molecular clock in a MPTP mouse model of Parkinson's disease. Neuromol. Med. 15, 238-251. https://doi.org/10.1007/s12017-012-8214-x
- Hirsch, E.C., and Hunot, S. (2009). Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol. 8, 382-397. https://doi.org/10.1016/S1474-4422(09)70062-6
- Keller, M., Mazuch, J., Abraham, U., Eom, G.D., Herzog, E.D., Volk, H.D., Kramer, A., and Maier, B. (2009). A circadian clock in macrophages controls inflammatory immune responses. Proc. Natl. Acad. Sci. USA 106, 21407-21412. https://doi.org/10.1073/pnas.0906361106
- Kim, T.W., Moon, Y., Kim, K., Lee, J.E., Koh, H.C., Kim, H., and Sun, W. (2011). Dissociation of progressive dopaminergic neuronal death and behavioral impairments by Bax deletion in a mouse model of Parkinson's diseases. PloS One 6, e25346. https://doi.org/10.1371/journal.pone.0025346
- Kojetin, D., Wang, Y., Kamenecka, T.M., and Burris, T.P. (2010). Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB. ACS Chem. Biol. 6, 131-134.
- Kondratova, A.A., and Kondratov, R.V. (2012). Circadian clock and pathology of the ageing brain. Nat. Rev. Neurosci. 13, 325. https://doi.org/10.1038/nrn3208
- Kudo, T., Loh, D.H., Truong, D., Wu, Y., and Colwell, C.S. (2011). Circadian dysfunction in a mouse model of Parkinson's disease. Exp. Neurol. 232, 66-75. https://doi.org/10.1016/j.expneurol.2011.08.003
- Lauretti, E., Di Meco, A., Merali, S., and Pratico, D. (2017). Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson's disease. Mol. Psychiatry 22, 280-286. https://doi.org/10.1038/mp.2016.47
-
Mang, G.M., La Spada, F., Emmenegger, Y., Chappuis, S., Ripperger, J.A., Albrecht, U., and Franken, P. (2016). Altered Sleep Homeostasis in Rev-erb
${\alpha}$ Knockout Mice. Sleep 39, 589-601. https://doi.org/10.5665/sleep.5534 - Marinova-Mutafchieva, L., Sadeghian, M., Broom, L., Davis, J.B., Medhurst, A.D., and Dexter, D.T. (2009). Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. J. Neurochem. 110, 966-975. https://doi.org/10.1111/j.1471-4159.2009.06189.x
- McGeer, P., Itagaki, S., Boyes, B., and McGeer, E. (1988). Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 38, 1285-1285. https://doi.org/10.1212/WNL.38.8.1285
-
Mogi, M., Harada, M., Kondo, T., Riederer, P., Inagaki, H., Minami, M., and Nagatsu, T. (1994a). Interleukin-1
${\beta}$ , interleukin-6, epidermal growth factor and transforming growth factor-${\alpha}$ are elevated in the brain from parkinsonian patients. Neurosci. Lett. 180, 147-150. https://doi.org/10.1016/0304-3940(94)90508-8 -
Mogi, M., Harada, M., Riederer, P., Narabayashi, H., Fujita, K., and Nagatsu, T. (1994b). Tumor necrosis factor-
${\alpha}$ (TNF-${\alpha}$ ) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. Neurosci. Lett. 165, 208-210. https://doi.org/10.1016/0304-3940(94)90746-3 - Monville, C., Torres, E.M., and Dunnett, S.B. (2006). Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model. J. Neurosci. Methods 158, 219-223. https://doi.org/10.1016/j.jneumeth.2006.06.001
- Musiek, E.S., Lim, M.M., Yang, G., Bauer, A.Q., Qi, L., Lee, Y., Roh, J.H., Ortiz-Gonzalez, X., Dearborn, J.T., Culver, J.P., et al. (2013). Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J. Clin. Invest. 123, 5389-5400. https://doi.org/10.1172/JCI70317
- Nguyen, K.D., Fentress, S.J., Qiu, Y., Yun, K., Cox, J.S., and Chawla, A. (2013). Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes. Science 341, 1483-1488. https://doi.org/10.1126/science.1240636
-
Preitner, N., Damiola, F., Zakany, J., Duboule, D., Albrecht, U., and Schibler, U. (2002). The orphan nuclear receptor REV-ERB
${\alpha}$ controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 110, 251-260. https://doi.org/10.1016/S0092-8674(02)00825-5 - Sauer, H., and Oertel, W. (1994). Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat. Neuroscience 59, 401-415. https://doi.org/10.1016/0306-4522(94)90605-X
- Solt, L.A., Wang, Y., Banerjee, S., Hughes, T., Kojetin, D.J., Lundasen, T., Shin, Y., Liu, J., Cameron, M.D., Noel, R., et al. (2012). Regulation of circadian behavior and metabolism by synthetic REV-ERB agonists. Nature 485, 62-68. https://doi.org/10.1038/nature11030
- Tansey, M.G., and Goldberg, M.S. (2010). Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol. Dis. 37, 510-518. https://doi.org/10.1016/j.nbd.2009.11.004
- Videnovic, A., Lazar, A.S., Barker, R.A., and Overeem, S. (2014). 'The clocks that time us'-circadian rhythms in neurodegenerative disorders. Nat. Rev. Neurol. 10, 683-693. https://doi.org/10.1038/nrneurol.2014.206
- Virgone-Carlotta, A., Uhlrich, J., Akram, M.N., Ressnikoff, D., Chretien, F., Domenget, C., Gherardi, R., Despars, G., Jurdic, P., Honnorat, J., et al. (2013). Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease. Glia 61, 1645-1658. https://doi.org/10.1002/glia.22546
- Walsh, S., Finn, D., and Dowd, E. (2011). Time-course of nigrostriatal neurodegeneration and neuroinflammation in the 6-hydroxydopamine-induced axonal and terminal lesion models of Parkinson's disease in the rat. Neuroscience 175, 251-261. https://doi.org/10.1016/j.neuroscience.2010.12.005
- Warner, T.T., and Schapira, A.H. (2003). Genetic and environmental factors in the cause of Parkinson's disease. Ann. Neurol. 53 Suppl 3, S16-23. https://doi.org/10.1002/ana.10487
-
Woldt, E., Sebti, Y., Solt, L.A., Duhem, C., Lancel, S., Eeckhoute, J., Hesselink, M.K., Paquet, C., Delhaye, S., Shin, Y., et al. (2013). Reverb-
${\alpha}$ modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy. Nat. Med. 19, 1039-1046. https://doi.org/10.1038/nm.3213
Cited by
- Small Molecule Modulators of the Circadian Molecular Clock With Implications for Neuropsychiatric Diseases vol.11, pp.1662-5099, 2019, https://doi.org/10.3389/fnmol.2018.00496
- Circadian Rhythm Abnormalities in Parkinson’s Disease from Humans to Flies and Back vol.19, pp.12, 2018, https://doi.org/10.3390/ijms19123911
- Recent Progress in Non-motor Features of Parkinson’s Disease with a Focus on Circadian Rhythm Dysregulation vol.37, pp.7, 2018, https://doi.org/10.1007/s12264-021-00711-x